Patent ID: 11958851
Assignee: KING FAISAL UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 9:
10. The method of claim 1, wherein the compound is selected from the group consisting of:
4-((3-chlorophenyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (1),
4-(m-tolylamino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (2),
4-((3-methoxyphenyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (3),
4-((3-(dimethylamino)phenyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (4),
4-((3,5-dimethylphenyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (5),
4-((3,5-dichlorophenyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (6),
4-((4-chlorophenyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (7),
4-(p-tolylamino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (8),
4-((4-(N,N-dimethylsulfamoyl)phenyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (9),
4-((2-methylpyridin-4-yl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (10),
4-((3-chlorobenzyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (11),
4-((3-(dimethylamino)propyl)amino)-1H-pyrrolo[3,2-c]quinoline-2,7-dicarboxylic acid (12),
or a pharmaceutically acceptable salt, stereoisomer, or solvate thereof.